The pro-cancer progression consequences of aberrant TGF-β pathway signaling involves stromal remodeling, promotion of tumor cell plasticity (facilitating migration, invasion and metastasis), neo-angiogenesis and immunosuppression with loss of immunosurveillance [7,8,9,10,11,12]. The gene discussed is TGFB1; the disease is cancer.